Seres Therapeutics logo

Seres Therapeutics

MCRB | NASDAQ
Chart Builder DCF Calculator
$1.41
+$0.01 (+0.71%)
At close: Nov 16, 2026, 4:00 PM ET
$1.53
+$0.12 (+8.18%)
After-hours: Nov 16, 2026, 6:35 PM ET
+0.71%

Rating

Updated: Nov 16, 2026
38.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #577/1021 (Top 57%)

Key Statistics

Market Data

Market Cap $14.37M
1D Range
1.38 1.70
52W Range
1.38 28.63

Valuation (TTM)

PE -0.28
PB 0.67
EV/EBITDA -0.51

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $12.00
Loading financial charts...

Profile

Seres Therapeutics, Inc. is a pioneering microbiome therapeutics firm dedicated to engineering bacterial consortia that modulate host cells and tissues to combat various diseases. Their flagship thera...

Sector Healthcare
Industry Biotechnology
Employees 66
IPO Date Jun 26, 2015
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 4, 2026
EPS
-$1.63
Miss -63.00%
REV
$593K
Miss -90.66%
Next Earnings
Mar 11, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$12.00
Upside
+751.06%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.